We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Zydus Seeks to Avoid Injunction On Generic of Lilly’s Strattera
Zydus Seeks to Avoid Injunction On Generic of Lilly’s Strattera
November 9, 2010
While Eli Lilly fights to maintain an injunction preventing generic versions of its attention-deficit drug Strattera from hitting the market, Zydus Pharmaceuticals USA hopes to jump past its generic competitors, saying the injunction does not apply to it.